Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma
Authors:
- Osamu NikkuniONOsamu Nikkuni
- Kyoichi KairaKKKyoichi Kaira
- Minoru ToyodaMTMinoru Toyoda
- Masato ShinoMSMasato Shino
- Koichi SakakuraKSKoichi Sakakura
- Katsumasa TakahashiKTKatsumasa Takahashi
- Hideyuki TominagaHTHideyuki Tominaga
- Noboru OriuchiNONoboru Oriuchi
- Masami SuzukiMSMasami Suzuki
- Misa IijimaMIMisa Iijima
- Takayuki AsaoTATakayuki Asao
- Masahiko NishiyamaMasahiko Nishiyama
- 30 May 2015
- journal article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 21 (4) , 1175-1181
Abstract
The aim of this study is to evaluate the clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with advanced laryngeal squamous cell carcinoma (LSCC). A total of 73 patients with advanced LSCC were retrospectively reviewed. Tumor sections were stained by immunohistochemistry for LAT1, 4F2hc, system ASC amino acid transporter-2 (ASCT2), cell proliferation by Ki-67, microvessel density (MVD) determined by CD34 and p53. A positive LAT1, 4F2hc and ASCT2 expression (staining more than a quarter) in the primary sites were recognized in 85, 80 and 45 %, respectively, and a high LAT1, 4F2hc and ASCT2 expression (staining more than a half) yielded 48, 31 and 18 %, respectively. High expression of LAT1 was significantly associated with lymph node metastasis, 4F2hc, ASCT2, Ki-67 and p53. The expression of LAT1 was significantly correlated with ASCT2, 4F2hc, cell proliferation, and MVD. By univariate analysis, there was no statistically significant relationship between LAT1 expression and prognosis in advanced LSCC. LAT1, 4F2hc and ASCT2 were highly expressed in patients with advanced laryngeal cancer. Our study suggests that the expression of LAT1 plays a crucial role in the metastasis and tumor progression in advanced LSCC.Keywords
This publication has 27 references indexed in Scilit:
- ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancerBritish Journal of Cancer, 2014
- LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer.2011
- High expression of L‐type amino‐acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non‐cancerous lesionsPathology International, 2011
- Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinomaLung Cancer, 2009
- CD98 Expression Is Associated with Poor Prognosis in Resected Non-Small-Cell Lung Cancer with Lymph Node MetastasesAnnals of Surgical Oncology, 2009
- Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancerBritish Journal of Cancer, 2008
- Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tractVirchows Archiv, 2007
- ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cellsAmerican Journal of Physiology-Cell Physiology, 2007
- The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human PapillomavirusJournal of Dental Research, 2007
- Expression of neutral amino acid transporter ASCT2 in human prostate.2003